2468 Embarcadero Way
Palo Alto
CA
94303
USA
(650) 354-1200
info@sentreheart.com
Product Categories
Related Content
January 6, 2017 — SentreHeart Inc. announced that it has completed the Stage I enrollment milestone in the aMAZE Trial ...
January 06, 2017
October 20, 2016 — SentreHeart Inc. announced in late September the closing of a $35 million Series D round of financing ...
October 20, 2016
October 13, 2016 — SentreHeart Inc. announced this week it has treated the first patients using the Eclipse Surgical ...
October 13, 2016
Feature | Left Atrial Appendage (LAA) Occluders| Dave Fornell
Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater risk of ...
May 20, 2016
October 28, 2015 — SentreHeart Inc. announced that it has received CE Mark approval for the Lariat Surgical Left Atrial ...
October 28, 2015
July 13, 2015 - The U.S. Food and Drug Administration (FDA) is alerting healthcare providers and patients about reports ...
July 13, 2015
July 1, 2015 - SentreHeart Inc. announced that it has received approval for an Investigational Device Exemption (IDE) ...
July 01, 2015
June 4, 2012 — SentreHeart Inc., a privately held medical device company, announced that it has recently completed a $26 ...
June 04, 2012
August 24, 2009 – Physicians at The Mount Sinai Medical Center were the first in the country to perform a nonsurgical ...
August 23, 2009